Breast Cancer : Targets and Therapy
Overview
Breast Cancer : Targets and Therapy is a scientific journal, published by Dove Medical Press since 2009 in English. The journal's country of origin is New Zealand.
Details
Details
Abbr.
Breast Cancer (Dove Med Press)
Publisher
Dove Medical Press
Start
2009
End
Continuing
e-ISSN
1179-1314
Country
New Zealand
Language
English
Metrics
Metrics
h-index / Ranks: 8264
43
SJR / Ranks: 4265
933
CiteScore / Ranks: 3145
6.70
Recent Articles
11.
Dong X, Meng J, Xing J, Jia S, Li X, Wu S
Breast Cancer (Dove Med Press)
. 2025 Feb;
17:103-113.
PMID: 39896200
Background: Young onset breast cancer, diagnosed in women under 50, is known for its aggressive nature and challenging prognosis. Precisely forecasting axillary lymph node metastasis (ALNM) is essential for customizing...
12.
Liessem A, Leimer U, Germann G, Kollensperger E
Breast Cancer (Dove Med Press)
. 2025 Jan;
17:79-102.
PMID: 39882382
Background: Adipokines, bioactive peptides secreted by adipose tissue, appear to contribute to breast cancer development and progression. While numerous studies suggest their role in promoting tumor growth, the exact mechanisms...
13.
Tan Y, Jiang H, Tian X, Ma F, Wang J, Zhang P, et al.
Breast Cancer (Dove Med Press)
. 2025 Jan;
17:67-78.
PMID: 39877556
Purpose: This study aims to explore the role of the non-luminal disease score (NOLUS) for everolimus in patients with hormone receptor-positive and human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced...
14.
Basingab F, Alshahrani O, Alansari I, Almarghalani N, Alshelali N, Alsaiary A, et al.
Breast Cancer (Dove Med Press)
. 2025 Jan;
17:27-51.
PMID: 39867813
Nanoparticle technology has revolutionized breast cancer treatment by offering innovative solutions addressing the gaps in traditional treatment methods. This paper aimed to comprehensively explore the historical journey and advancements of...
15.
Belluzzi L, Martinelli G, Medici B, Farina A, Martinelli E, Canino F, et al.
Breast Cancer (Dove Med Press)
. 2025 Jan;
17:53-66.
PMID: 39867812
In recent years, new anticancer drugs have been investigated and approved for the treatment of breast cancer based on improved survival outcomes. However, these new treatments have specific class-related side...
16.
Zhang J, Li L, Cao M, Liu X, Yi Z, Liu S, et al.
Breast Cancer (Dove Med Press)
. 2025 Jan;
17():11-25.
PMID: 39811603
Purpose: Cell division cycle protein 45 (CDC45) plays a crucial role in DNA replication. This study investigates its role in breast cancer (BC) and its impact on tumor progression. Methods:...
17.
Khairani A, Harmonia S, Chou Y, Alfarafisa N, Ramadhanti J
Breast Cancer (Dove Med Press)
. 2025 Jan;
17():1-10.
PMID: 39811602
Purpose: The high mortality rate of breast cancer motivates researchers to search for effective treatments. Due to their ability to simulate human conditions, xenograft models such as CDX (Cell line-Derived...
18.
Bozer A, Yilmaz C, Cetin Tuncez H, Kocatepe Cavdar D, Adibelli Z
Breast Cancer (Dove Med Press)
. 2025 Jan;
16:1005-1017.
PMID: 39759838
Purpose: In breast cancer (BC), neoadjuvant chemotherapy (NAC) responses can be categorized as concentric shrinkage (CS), non-concentric shrinkage (non-CS), and complete response, influencing surgical planning and survival. This study evaluates...
19.
Meng S, Cao Y, Lu L, Li X, Sun S, Jiang F, et al.
Breast Cancer (Dove Med Press)
. 2024 Dec;
16:993-1004.
PMID: 39720358
Aim: The study aimed to culture organoids from tissues of patients with breast cancer (BC) and use the organoids to measure the sensitivity to quercetin and its combination with chemotherapeutic...
20.
Guo Y, Liao J, Li S, Shang Y, Wang Y, Wu Q, et al.
Breast Cancer (Dove Med Press)
. 2024 Dec;
16:981-991.
PMID: 39720357
Background: Histological grade is an acknowledged prognostic factor for breast cancer, essential for determining clinical treatment strategies and prognosis assessment. Our study aims to establish intra- and peritumoral radiomics models...